D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 25,671 210 World Ranking 7610 National Ranking 88

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Endocrinology
  • Diabetes mellitus

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Glucagon-like peptide-1, Incretin and Insulin. Her Internal medicine research includes elements of Diabetes mellitus, Type 2 diabetes and Dipeptidyl peptidase. She interconnects Vildagliptin and Enzyme inhibitor in the investigation of issues within Dipeptidyl peptidase.

In her study, which falls under the umbrella issue of Endocrinology, Creatinine and Renal function is strongly linked to Pharmacokinetics. Her Glucagon-like peptide-1 research incorporates elements of Liraglutide, Gastric emptying, Impaired glucose tolerance, Glycemic and Biological activity. Carolyn F. Deacon combines subjects such as Sitagliptin, Enzyme, Hormone, Pharmacology and Dipeptidyl peptidase-4 with her study of Incretin.

Her most cited work include:

  • Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients (792 citations)
  • Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects (762 citations)
  • Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo (719 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Internal medicine, Endocrinology, Glucagon-like peptide-1, Incretin and Type 2 diabetes. Her Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Dipeptidyl peptidase and Dipeptidyl peptidase-4. Her work in Insulin, Postprandial, Hormone, Gastric inhibitory polypeptide and Glucagon secretion is related to Endocrinology.

As a part of the same scientific study, Carolyn F. Deacon usually deals with the Glucagon-like peptide-1, concentrating on Peptide and frequently concerns with Amide and Radioimmunoassay. Her studies deal with areas such as Meal, Enteroendocrine cell and Glucose homeostasis, Insulin resistance as well as Incretin. She has researched Type 2 diabetes in several fields, including Metformin and Islet.

She most often published in these fields:

  • Internal medicine (86.25%)
  • Endocrinology (84.17%)
  • Glucagon-like peptide-1 (45.42%)

What were the highlights of her more recent work (between 2015-2021)?

  • Internal medicine (86.25%)
  • Endocrinology (84.17%)
  • Glucagon-like peptide-1 (45.42%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Internal medicine, Endocrinology, Glucagon-like peptide-1, Glucagon and Incretin. Her studies in Internal medicine integrate themes in fields like Diabetes mellitus, Type 2 diabetes and Dipeptidyl peptidase-4. She regularly ties together related areas like Receptor in her Endocrinology studies.

Her Glucagon-like peptide-1 research includes themes of Vildagliptin, Gastric inhibitory polypeptide, Central nervous system, Metabolite and Chocolate milk. Her work carried out in the field of Glucagon brings together such families of science as Cholecystokinin, Glucose clamp technique and Glycogenolysis. Her Incretin research is multidisciplinary, incorporating elements of Paracrine signalling, Hormone, Insulin resistance, Glucose homeostasis and Pancreatitis.

Between 2015 and 2021, her most popular works were:

  • Comparative review of dipeptidyl peptidase‐4 inhibitors and sulphonylureas (106 citations)
  • Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas. (62 citations)
  • Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia (60 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Endocrinology

Carolyn F. Deacon focuses on Endocrinology, Internal medicine, Glucagon-like peptide-1, Incretin and Glucagon. Her Glucagon secretion, Insulin, Secretion and Pancreatic polypeptide study, which is part of a larger body of work in Endocrinology, is frequently linked to Peptide YY, bridging the gap between disciplines. Carolyn F. Deacon has included themes like Neprilysin, Candoxatril and Chocolate milk in her Internal medicine study.

Her Glucagon-like peptide-1 research is multidisciplinary, relying on both Weight loss, Gastric inhibitory polypeptide, Central nervous system, Postprandial and Appetite. Her work deals with themes such as Metformin, Hormone, Paracrine signalling and Glucose homeostasis, which intersect with Incretin. Her Glucagon study deals with Glucose clamp technique intersecting with Radioimmunoassay and Endogeny.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll;Thure Krarup;Carolyn F. Deacon;Sten Madsbad.
Diabetes (2001)

1084 Citations

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

Carolyn F Deacon;Michael A Nauck;Maibritt Toft-Nielsen;Lone Pridal.
Diabetes (1995)

1062 Citations

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

C F Deacon;A H Johnsen;J J Holst.
The Journal of Clinical Endocrinology and Metabolism (1995)

983 Citations

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

Lene Hansen;Carolyn F. Deacon;Cathrine Ørskov;Jens J. Holst.
Endocrinology (1999)

762 Citations

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

Jens J. Holst;Carolyn F. Deacon.
Diabetes (1998)

735 Citations

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Gary A. Herman;Arthur Bergman;Catherine Stevens;Paul Kotey.
The Journal of Clinical Endocrinology and Metabolism (2006)

662 Citations

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

Carolyn F. Deacon;Michael A. Nauck;Juris Meier;Katrin Hücking.
The Journal of Clinical Endocrinology and Metabolism (2000)

616 Citations

Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review

C. F. Deacon.
Diabetes, Obesity and Metabolism (2011)

582 Citations

The incretin system and its role in type 2 diabetes mellitus.

Jens Juul Holst;Tina Vilsbøll;Carolyn F. Deacon.
Molecular and Cellular Endocrinology (2009)

565 Citations

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

C F Deacon;T E Hughes;J J Holst.
Diabetes (1998)

517 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Carolyn F. Deacon

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 528

Filip K. Knop

Filip K. Knop

University of Copenhagen

Publications: 166

Peter R. Flatt

Peter R. Flatt

University of Ulster

Publications: 142

Michael Horowitz

Michael Horowitz

University of Adelaide

Publications: 138

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 130

Sten Madsbad

Sten Madsbad

Copenhagen University Hospital

Publications: 123

Bo Ahrén

Bo Ahrén

Lund University

Publications: 113

Karen L. Jones

Karen L. Jones

University of Adelaide

Publications: 101

Michael A. Nauck

Michael A. Nauck

Ruhr University Bochum

Publications: 81

David A. D'Alessio

David A. D'Alessio

Duke University

Publications: 74

Juris J. Meier

Juris J. Meier

Ruhr University Bochum

Publications: 60

Fiona M. Gribble

Fiona M. Gribble

University of Cambridge

Publications: 53

Frank Reimann

Frank Reimann

University of Cambridge

Publications: 51

Yutaka Seino

Yutaka Seino

Kyoto University

Publications: 49

Hans-Ulrich Demuth

Hans-Ulrich Demuth

Fraunhofer Society

Publications: 45

Carel W. le Roux

Carel W. le Roux

University College Dublin

Publications: 44

Trending Scientists

Brigitte D'Andrea-Novel

Brigitte D'Andrea-Novel

Mines ParisTech

Ken-ya Hashimoto

Ken-ya Hashimoto

University of Electronic Science and Technology of China

Zhiping Zheng

Zhiping Zheng

Xiamen University

Shinji Takeoka

Shinji Takeoka

Waseda University

N. Asger Mortensen

N. Asger Mortensen

University of Southern Denmark

Eric Alani

Eric Alani

Cornell University

John P. Reganold

John P. Reganold

Washington State University

Bernard Monsarrat

Bernard Monsarrat

Federal University of Toulouse Midi-Pyrénées

Leiv Sigve Håvarstein

Leiv Sigve Håvarstein

Norwegian University of Life Sciences

Valakunja Nagaraja

Valakunja Nagaraja

Indian Institute of Science Bangalore

Fusao Tomita

Fusao Tomita

Hokkaido University

Luis Miguel Ortega-Mora

Luis Miguel Ortega-Mora

Complutense University of Madrid

Arun Bhakta Shrestha

Arun Bhakta Shrestha

International Centre for Integrated Mountain Development

Istvan Laszlo

Istvan Laszlo

National Oceanic and Atmospheric Administration

Sharron J. Lennon

Sharron J. Lennon

University of Delaware

Valentine Wakelam

Valentine Wakelam

Centre national de la recherche scientifique, CNRS

Something went wrong. Please try again later.